EDEN — Eden Biosolutions Share News
0.000.00%
Last trade - 00:00- £19.68m
- £18.44m
- £4.30m
Investor Presentation via Investor Meet Company
Brief: Eden Research FY Operating Loss £1.9 Mln
Appointment of Non-Executive Director
Preliminary results for the year ended 31 Dec 2023
Board Change
Brief: Eden Research Sees FY Revenue Up 72%
Trading Update
Holding(s) in Company
Mevalone Approval in the State of California
Brief: Eden Research Announces Ecovelex™2023 Approval In Italy
Ecovelex™2023 Approval in Italy
Small Cap Virtual Investor Conference
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Completion of Conditional Placing
Brief: Eden Research Reports H1 Revenue 1.14 Mln Stg
Half Yearly Report
Capital Raising Update